oxazoles has been researched along with Bacterial Disease in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (23.33) | 18.7374 |
| 1990's | 6 (20.00) | 18.2507 |
| 2000's | 6 (20.00) | 29.6817 |
| 2010's | 11 (36.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rademacher, J; Welte, T | 1 |
| Al-Obeid, S; Dmitrieva, N; Gales, AC; M Blondeau, J; Petukhova, I; Rossi, F; Wilcox, MH | 1 |
| Bast, LK; Hennes, E; Krumm, C; Lanfer, F; Richter, L; Schmidt, M; Seymen, R; Tiller, JC | 1 |
| Alcorn, HW; Fang, E; Flanagan, S; Marbury, TC; Minassian, SL; Morris, D; Ponnuraj, R; Prokocimer, P | 1 |
| Bremner, JB; Brkic, Z; Hammer, KA; Keller, PA; Kemker, I; King, AM; Lyras, D; Pyne, SG; Riley, TV; Schröder, DC; Somphol, K; Tague, AJ; Wales, SM | 1 |
| Arrieta, AC; Bradley, JS; Capparelli, E; Flanagan, SD; Jacobs, R; Prokocimer, P | 1 |
| Bagwell, CL; Moloney, MG; Yaqoob, M | 1 |
| Gadakh, AV; Karale, BK; Pandit, C; Rindhe, SS | 1 |
| Muralikrishna, A; Padmaja, A; Padmavathi, V; Rajasekhar, C | 1 |
| Chen, L; Franzblau, SG; Liu, X; Lu, X; Wan, B; You, Q; Zhou, C | 1 |
| Barman, TK; Kalia, V; Khan, S; Mathur, T; Raj, VS; Rattan, A; Singhal, S; Upadhyay, DJ | 1 |
| Appelbaum, PC; Ednie, LM; Jacobs, MR; Rattan, A | 1 |
| Barbachyn, MR; Brickner, SJ; Ford, CW; Hamel, JC; Hutchinson, DK; Moerman, JK; Stapert, D; Wilson, DM; Yancey, RJ | 1 |
| Barbachyn, MR; Ford, CW; Hamel, JC; Hutchinson, DK; Moerman, JK; Stapert, D; Zurenko, GE | 1 |
| Allwine, DA; Brickner, SJ; Ford, CW; Gleave, DM; Lovasz, KD; Manninen, PR; Rohrer, DC; Tucker, JA; Zurenko, GE | 1 |
| Barbachyn, MR; Brickner, SJ; Ford, CW; Gadwood, RC; Garmon, SA; Grega, KC; Hutchinson, DK; Munesada, K; Reischer, RJ; Taniguchi, M; Thomasco, LM; Toops, DS; Yamada, H; Zurenko, GE | 1 |
| Heinzl, S; Holtfoht, A; Roloff, T; Ziegler, A | 1 |
| Flückiger, U | 1 |
| Senior, K | 1 |
| Clemett, D; Markham, A | 1 |
| Matowe, WC; Phillips, OA | 1 |
| Akimitsu, N; Kaito, C; Sekimizu, K; Watanabe, H | 1 |
| Hopf, U; Stockhausen, G | 1 |
| Dulaney, EL; Frost, BM; Valiant, ME | 1 |
| Bartholomew, PT; Forbes, M; Gregory, WA; McRipley, RJ; Slee, AM; Wuonola, MA; Zajac, I; Zawada, MJ | 1 |
| Albini, E; Carenzi, A; Chiarino, D; Della Bella, D; Napoletano, M; Sala, A | 1 |
| Gavrilov, G; Majdrakov, G; Stefanova, G | 1 |
| Fairley, KF | 1 |
| Dianese, G | 1 |
7 review(s) available for oxazoles and Bacterial Disease
| Article | Year |
|---|---|
[New antibiotics - standstill or progress].
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ephedrine; Humans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Penicillanic Acid; Phenobarbital; Staphylococcal Infections; Tazobactam; Theophylline; Triazoles | 2017 |
Oxazolidinones: new antibacterial agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Community-Acquired Infections; Cross Infection; Humans; Oxazoles; Oxazolidinones; Penicillin Resistance | 1997 |
Design, synthesis, and evaluation of novel oxazolidinone antibacterial agents active against multidrug-resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Oxazoles; Structure-Activity Relationship | 1998 |
[Oxazolidinones. A new anti-infective principle].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones | 1999 |
[On new antiviral drugs, new viruses and old known bacteria].
Topics: Anti-Bacterial Agents; Antiviral Agents; Bacteria; Bacterial Infections; Enterovirus; Enterovirus Infections; Humans; Oxadiazoles; Oxazoles; Virus Diseases; Viruses | 1999 |
Linezolid.
Topics: Acetamides; Animals; Bacteria; Bacterial Infections; Humans; Linezolid; Oxazoles; Oxazolidinones | 2000 |
Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Humans; Macrolides; Oxazoles; Patents as Topic; Quinolones | 2001 |
2 trial(s) available for oxazoles and Bacterial Disease
| Article | Year |
|---|---|
Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Cross-Over Studies; Female; Humans; Kidney; Kidney Failure, Chronic; Liver; Liver Diseases; Male; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Prodrugs; Renal Dialysis; Tetrazoles; Young Adult | 2014 |
Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Anti-Bacterial Agents; Bacterial Infections; Biological Availability; Blood Chemical Analysis; Child; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Urine | 2016 |
21 other study(ies) available for oxazoles and Bacterial Disease
| Article | Year |
|---|---|
Susceptibility testing and reporting of new antibiotics with a focus on tedizolid: an international working group report.
Topics: Americas; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Europe; Humans; International Cooperation; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Saudi Arabia | 2017 |
Poly(2-oxazoline)-Antibiotic Conjugates with Penicillins.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Stability; Escherichia coli; Escherichia coli Infections; Humans; Hydrolysis; Oxazoles; Penicillinase; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 2017 |
Synthesis and antimicrobial activity of binaphthyl-based, functionalized oxazole and thiazole peptidomimetics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Humans; Microbial Sensitivity Tests; Naphthalenes; Oxazoles; Peptidomimetics; Thiazoles | 2015 |
Oxazolomycins: natural product lead structures for novel antibacterials by click fragment conjugation.
Topics: Amides; Anti-Bacterial Agents; Bacterial Infections; Biological Products; Escherichia coli; Humans; Lactams; Microbial Sensitivity Tests; Molecular Structure; Oxazoles; Pyrrolidinones; Spiro Compounds; Staphylococcus aureus | 2010 |
Synthesis and antimicrobial activity of novel fluorine containing 4-(substituted-2-hydroxybenzoyl)-1H-pyrazoles and pyrazolyl benzo[d]oxazoles.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacillus subtilis; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Escherichia coli; Fluorine; Humans; Microbial Sensitivity Tests; Oxazoles; Pseudomonas aeruginosa; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship | 2010 |
Synthesis and antimicrobial activity of pyrrolyl/pyrazolyl arylaminosulfonylmethyl 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Oxazoles; Thiadiazoles; Triazoles | 2011 |
Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Humans; Imidazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazoles; Thiazoles; Tuberculosis | 2012 |
Anti-anaerobic potential of ranbezolid: insight into its mechanism of action against Bacteroides fragilis.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Cell Wall; Foreign Bodies; Furans; Mice; Microbial Sensitivity Tests; Microbial Viability; Oxazoles; Protein Biosynthesis; Time Factors; Treatment Outcome | 2013 |
Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Culture Media; Furans; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Humans; Kinetics; Microbial Sensitivity Tests; Oxazoles | 2003 |
In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections.
Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Injections, Intravenous; Injections, Subcutaneous; Linezolid; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus aureus; Vancomycin | 1996 |
Synthesis and antibacterial activity of [6,5,5] and [6,6,5] tricyclic fused oxazolidinones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Indicators and Reagents; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Molecular Structure; Oxazoles; Structure-Activity Relationship | 1998 |
FDA approves first drug in new class of antibiotics.
Topics: Anti-Infective Agents; Bacterial Infections; Drug Approval; Humans; Oxazoles; Oxazolidinones; United States; United States Food and Drug Administration | 2000 |
Linezolid approval brings new treatment option for resistant bacteria.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Infections; Drug Interactions; Drug Resistance, Microbial; Humans; Linezolid; Oxazoles; Oxazolidinones | 2000 |
Silkworm larvae as an animal model of bacterial infection pathogenic to humans.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Bombyx; Disease Models, Animal; Drug Therapy, Combination; Humans; Inhibitory Concentration 50; Larva; Lethal Dose 50; Methicillin Resistance; Microbial Sensitivity Tests; Oxazoles; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin; Vibrio cholerae | 2002 |
[Chemotherapy of bacterial infection in dental practice. Field study with co-trimoxazol].
Topics: Bacterial Infections; Drug Evaluation; Humans; Mouth Diseases; Oxazoles | 1975 |
Antibacterial activity of 3-(1-methyl-5-nitro-2-imidazolylmethylideneamino)-2-oxazolidinone.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Disease Models, Animal; Female; Furazolidone; Kidney Diseases; Male; Mice; Mice, Inbred Strains; Nitroimidazoles; Oxazoles; Rats; Rats, Inbred Strains | 1975 |
Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Female; Mice; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones | 1987 |
Synthesis and antibacterial properties of 7-[2-(3-substituted-5-isoxazolyl)-2-methoxyiminoacetamido]cep halospora nic acid derivatives.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Biological Availability; Cephalosporins; Isomerism; Isoxazoles; Microbial Sensitivity Tests; Oxazoles; Rats; Structure-Activity Relationship | 1987 |
Treatment of chronic pyelonephritis with urovalidin.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacterial Infections; Chronic Disease; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Oxazoles; Phenazopyridine; Pyelonephritis; Pyridines | 1972 |
Diagnosis and treatment of pyelonephritis.
Topics: Ampicillin; Bacterial Infections; Cephalexin; Erythromycin; Female; Gentamicins; Humans; Kidney Diseases; Leukocyte Count; Nalidixic Acid; Nitrofurantoin; Oxazoles; Pyelonephritis; Pyuria; Recurrence; Sulfonamides; Ureteral Diseases | 1973 |
[Trial in pediatrics of a new antibiotic association: dicloxacillin and ampicillin].
Topics: Ampicillin; Bacterial Infections; Child; Child, Preschool; Dicloxacillin; Drug Combinations; Drug Tolerance; Female; Humans; Infant; Infant, Newborn; Male; Oxazoles; Penicillins | 1972 |